Geneva, August 18 (Xinhua) the World Health Organization (who) director general Tan Desai said on the 18th that the quickest way to end the new epidemic and reopen the economy is to protect the most at-risk groups around the world, rather than just protect the entire population of some countries. He reiterated that “nationalism” in the supply of anti epidemic materials, especially vaccines, should be avoided. Speaking at the same day’s press conference, Tan Desai said that from the perspective of logistics and material supply, the new crown pandemic is one of the most serious challenges facing the international community. While leaders want to protect their own people first, collective action is needed to deal with the pandemic. “We have learned from the bitter lessons that the fastest way to end the epidemic and reopen the economy is to start by protecting the most at-risk people around the world, not just the entire population of some countries.” < / P > < p > in the case of new coronal vaccines, who has been working through extensive consultations to develop a new framework to guide equitable and equitable access to vaccines and other response tools for all countries. The international community needs to prevent “vaccine nationalism”. Once a successful vaccine has been identified, who will provide advice on the proper and rational use of the vaccine, and recommends a two-stage distribution of the vaccine, according to tandesse. In the novel coronavirus pneumonia, the vaccine will be allocated proportionally to all participating countries in the international cooperation initiative to fight the new crown accelerator tool accelerator in the first stage, so as to reduce the overall risk. In the second stage, the threats and vulnerabilities faced by countries will be considered. For most countries, 20% of the population allocated in the first phase will cover most high-risk groups. Tan Desai pointed out that the front-line staff in health and social care institutions should be given priority because they are essential to the treatment of patients with new crowns and the protection of the public, and they often have close contact with the risk groups with high mortality rate of new crowns. < / P > < p > he stressed that sharing Limited supplies strategically and globally was in the interests of each country. In the face of the new crown, “no one is safe until everyone is safe” and “no country has access to the R & D, manufacturing and supply chains of all essential drugs and materials”. He called on all to work together to ensure that all key staff members are protected and that those in need have access to proven new crown medicines such as dexamethasone.